Effect of substitution of distillers grains and glycerin for steam-flaked corn in finishing cattle diets on growth performance and carcass characteristics.

An experiment was conducted to determine the effect of substituting modified corn distillers grains with solubles (DGS) or crude soy glycerin (CG) for steam-flaked corn (SFC) in finishing diets on growth performance and carcass characteristics. Treatments were arranged as a 2 × 2 factorial with DGS (0% or 40%) and CG (0% or 10%) replacing dietary SFC in a basal diet. Growth performance and carcass traits were measured on 48 individually fed crossbred yearling cattle (21 steers and 27 heifers; 380 ± 37 kg). Cattle were randomly allotted to 48 Calan gate bunks. After the first 28 days, nine animals were removed from the study for health reasons or observed confirmation of consumption of feed from unassigned Calan gate bunk (n = 39). After the feeding period, cattle were harvested in two groups on day-124 and day-173. No DGS × CG interactions were observed (P > 0.10) for any dependent growth performance or carcass characteristic variable tested. Cattle-fed DGS as 40% of diet dry matter (DM) had greater (P< 0.01) dry matter intake (DMI), while CG inclusion at 10% of diet DM did not affect DMI (P = 0.16). Carcass-adjusted average daily gain (ADG) was not affected by DGS (P = 0.73) or CG (P = 0.28). Decreased (P = 0.03) carcass-adjusted gain-to-feed (G:F) was observed as the main effect of DGS. Greater DMI resulting from feeding DGS as 40% of diet DM appears to have driven the tendency for reduced G:F. Hot carcass weight, longissimus muscle area, 12th rib fat depth, yield grade, and marbling score were not (P> 0.10) influenced by DGS or CG. However, kidney, pelvic, fat (KPH) was increased (P = 0.01) when cattle were fed DGS as 40% of diet DM. Based on the findings presented, it is concluded that CG can substitute up to 10% of SFC in the diet without negatively affecting cattle growth performance or carcass characteristics, regardless of DGS inclusion as 40% of the diet DM.

Livestock producers have an opportunity to improve sustainably through the utilization of co-products of the bio-fuel industry through cattle feeding. Crude glycerin, although less commonly fed compared to distillers grains, provides an opportunity for cattle feeders to increase the versatility of feed ingredient sources without compromising performance. The present study examined the effect of substituting modified corn distillers grains and crude soy glycerin for steam­flaked corn in beef cattle finishing diets on cattle growth performance and carcass characteristics. Growth performance was not influenced by treatment suggesting that crude glycerin and modified corn distillers grains in finishing diets were effective substitutions for steam­flaked corn when market price permits.

Effect of inclusion of distillers grains with solubles and crude glycerin in beef cattle finishing diets on ruminal fermentation and fatty acid biohydrogenation.

An experiment was conducted to evaluate the impact of feeding bio-fuel co-products on ruminal fermentation characteristics and composition of omasal digesta flow. Four ruminally cannulated Holstein steers (371 ± 5 kg) were used in a 4 × 4 Latin Square design. Omasal sample collection and triple marker technique was used to quantify fatty acid omasal flow. Treatments were applied as a 2 × 2 factorial where a steam flaked corn (SFC) basal diet (DGS-N CG-N) was replaced with 40% of diet DM as corn distillers grains (DGS; DGS-Y CG-N) or 10% of diet DM as crude glycerin (DGS-N CG-Y) or 40% of diet DM distillers grains and 10% of diet DM as crude glycerin (DGS-Y CG-Y). No effects were observed for the interaction of DGS and glycerin on measured rumen characteristics. Dietary inclusion of glycerin decreased (P = 0.05) ruminal content 4-h post feeding on a DM basis but did not influence DMI (P = 0.64). Feeding DGS had no effect (P = 0.34) on particulate passage to the omasum (kg/d) in spite of greater (P = 0.04) DMI. Feeding DGS reduced flow rate (% of rumen volume/h) (P = 0.05) but did not affect total VFA concentration (P = 0.46) or average ruminal pH (P = 0.72). No differences (P > 0.05) were observed in ruminal parameters when feeding glycerin, besides ruminal particulate content (kg) on DM basis (P = 0.05). An interaction of DGS and glycerin affected intake of stearic (P < 0.01), linoleic (P < 0.01), and linolenic acid (P < 0.01). An interaction of DGS and glycerin did not affect individual fatty acid flow with respect to intake for stearic (P = 0.17), linoleic (P = 0.18), or linolenic acid (P = 0.66). Dietary inclusion of glycerin had no impact on g of linolenic (P = 0.16) or linoleic (P = 0.32) acid transformed. A trend was identified for cattle fed diets with glycerin to have increased (P = 0.07) grams of conjugated linoleic acid (CLA; C18:2 cis-9, trans-11) per gram of linoleic acid intake, with no impact on the percent of saturated fat (P = 0.44) or unsaturated fat (P = 0.43) in omasal flow. For cattle fed diets with DGS, fewer grams of linoleic (P < 0.01) and linolenic (P < 0.01) were present in digesta flow per gram of intake. Inclusion of DGS in the treatment diets also increased (P < 0.01) stearic acid flow (g) and CLA flow (g) per gram of stearic and linoleic acid intake, respectively. Observed differences in CLA proportion post fermentation may indicate interrupted biohydrogenation when glycerin is fed.

Inclusion of corn grain in cattle diets increases the dietary concentration of unsaturated fatty acids like linoleic acid. Ethanol co-products are most often made from corn grain in the United States and contain concentrated amounts of unsaturated fatty acids. Concerns with feeding ethanol co-products could arise for cattle producers because the increased unsaturated fat concentration of meat products can lead to shorter meat shelf life. Co-products from bio-diesel production, such as crude glycerin, can be used to replace grain and reduce total unsaturated fat without affecting dietary energy. This study evaluated the effect of ruminal microbes to transform unsaturated fatty acids to saturated fatty acids in diets where steam-flaked corn was replaced by co-products such as distillers grains and crude glycerin. When steam-flaked corn is replaced with distillers grains in beef cattle diets, the fat composition was shifted to a higher proportion of saturated fatty acids due to increased biohydrogenation by ruminal microbes. However, feeding crude glycerin in place of steam-flaked corn increased conjugated linoleic acid, an intermediate product of the fatty acid transformation pathway. Increased conjugated linoleic acid indicates glycerin may impact the ability of microbes to transform linoleic acid to a saturated form.

Effects of feeding corn containing an alpha-amylase gene on the performance and digestibility of growing cattle.

Two growth performance studies and two digestibility trials were conducted to evaluate the effects of feeding Enogen Feed Corn silage and corn grain to growing cattle. In Exp. 1, there were a total of four diets offered for ad libitum intake. The four diets consisted of two varieties of corn (Enogen Feed Corn [EFC] vs. yellow #2 corn [CON]) with two different methods of corn processing (dry-rolled [DR] vs. whole-shelled [WS]) and were formulated to provide 1.13 Mcal NEg/kg dry matter (DM); corn grain was 28.6% of diet DM. Average daily gain (ADG) and ending body weight tended to be greater for calves fed EFC than for those fed CON (P < 0.10). Gain:feed (G:F) was better for calves fed EFC (P < 0.01), improving by 5.5% over calves fed CON. In Exp. 2, a digestibility trial was conducted using seven cannulated Holstein steers fed the same diets from Exp. 1. Ruminal pH was not affected by corn variety (P > 0.82). Liquid passage rate was greater for CON-fed calves and associated with lower digestibility. Total tract DM and organic matter (OM) digestibilities were greater for EFC-fed calves (P < 0.04). In Exp. 3, there were four diets offered for ad libitum intake. Dietary factors were arranged as a 2 × 2 factorial and consisted of two hybrids of corn silage (EFC silage [EFC-S] vs. control silage [CON-S]) and two varieties of corn grain (EFC grain [EFC-G] vs. control [CON-G]; both were dry-rolled). Diets were formulated to provide 1.11 Mcal NEg/kg DM; corn grain was 38.5% of diet DM, and corn silage was 40% of diet DM. ADG was 6.0% greater (P < 0.01) and G:F was numerically (P < 0.14) 3.3% greater for calves fed EFC-S than for those fed CON-S, but substituting EFC-G for CON-G did not affect ADG or G:F. In Exp. 4, a digestibility trial was conducted using eight cannulated beef steers fed the same diets as Exp. 3. Liquid passage rate (P > 0.20), ruminal pH (P > 0.23), and ruminal total volatile fatty acid concentrations (P > 0.27) were unaffected by treatment. Total tract digestibilities of DM and OM were numerically greater by 2.5% and 2.2%, respectively, for calves fed the EFC-S compared with those fed CON-S. Feeding a corn hybrid containing alpha-amylase enzyme improved G:F of growing calves. Feeding EFC can benefit the beef industry by allowing less processing of grain without sacrificing performance.

Effect of a multicarbohydrase containing α-galactosidase in sow lactating diets with varying energy density.

Sow productivity improvements are associated with high energetic demand due to increasing prolificity. The reproductive life and longevity of sows, and the readiness for weaning of the offspring may be impaired when sows loose significant body weight (BW) during lactation. The impact of a multicarbohydrase containing α-galactosidase on a low energy dense lactation diet was evaluated in this study. Two-hundred and eight sows (208 ±â€…25.2 kg) were blocked by parity and BW to one of four treatments, in which a corn-soybean meal diet was formulated to have varying levels of added fat (0, 1.5%, and 3%) to titrate an energy density model. A fourth treatment replicated the 0% added fat formulation with enzyme supplementation at 250 g/tonne. Sows were weighed individually on entry, post-farrow (by calculation) and at weaning. Daily feed intakes (ADFI) and caloric intake were used for calculation of sow feed efficiency (FE) and caloric efficiency. Litter performance was characterized at birth, and size was standardized within 24h of farrow and within treatment to ensure uniform litter sizes. Average wean weight and pre-weaning mortality were determined. Piglets were weighted individually to study litter weight distribution. Data was analyzed as a randomized completely block design, using sow as the experimental unit, treatment as the main effect, and standardized average weight and litter sizes as covariates where appropriate. Although sows fed a multicarbohydrase had lower standardized litter size (P < 0.001), average wean weight was higher in this group and equivalent to the 3% added fat treatment. Enzyme supplementation tended to reduce the proportion of light weight pigs (BW < 4.1kg) within the litter, when compared with the 0% added fat diet (P < 0.1). The multicarbohydrase tended to increased sow ADFI (P < 0.10), although sows from all treatments had equivalent caloric intakes during lactation (P > 0.1). Enzyme supplementation yielded significant improvements in sow FE (P < 0.01), similar to the 3% added fat group. Thus, the carbohydrase degrading enzyme tested in this study improved the efficiency of sows, while increasing average wean weights of the offspring, suggesting an improvement in nutrient digestion and/or metabolic efficiency from typical lactation diets.

Influence of hay feeding method, supplement moisture, or access time on intake and waste by beef cows.

Experiments were performed to determine the effects of feeding method and hay processing (Experiment 1), energy supplement moisture content and feeding method (Experiment 2), and access time to hay (Experiment 3) on cow body weight (BW), dry matter intake (DMI), and hay or energy supplement intake and waste. Experiment 1 was designed as a 4 × 4 Latin Square using 48 multiparous, late-gestating, Angus cows (626 kg initial BW). Cows were stratified by age and BW into four treatment groups (n = 12 cows/group); treatment groups were then initially assigned randomly to treatments in a sequence of preset Latin Square periods. In Experiment 1, round bales were processed and delivered on the pen surface or in a bunk, or left unprocessed and delivered in a hay ring or rolled out on the pen surface. Experiment 2 was designed as a 6 × 6 Latin Square utilizing 54 multiparous, late-gestating, Angus cows (616 kg initial BW). Cows were stratified by age and BW into treatment groups (n = 9 cows/group); treatment groups were then initially assigned randomly to treatments in a sequence of preset Latin Square periods. In Experiment 2, corn screenings (CS) or wet beet pulp (BP) were fed in a structure (inverted tire or bunk) or BP only on the pen surface. Experiment 3 was designed as a replicated 3 × 3 Latin Square utilizing 24 multiparous, late-gestating, Angus cows (584 kg initial BW). Cows were stratified by age and BW into treatment groups (n = 8 cows/group); treatment groups were then initially assigned randomly to treatments in a sequence of preset Latin Square periods. In Experiment 3, cows were permitted access to round-bales in a hay ring for 6, 14, or 24 h. In Experiment 1, hay DMI was not affected (P ≥ 0.579). Hay waste was greater (P ≤ 0.007) when hay, processed or not, was fed on the pen surface. In Experiment 2, hay DMI was greatest (P ≤ 0.011) for cows fed no supplement and those fed CS in a bunk. Feeding BP in a bunk led to the greatest (P ≤ 0.003) hay waste. In Experiment 3, cows permitted 6-h access consumed and wasted less (P < 0.001) hay compared with those permitted longer access; BW was unaffected (P ≥ 0.870). In these experiments, cows fed hay on the pen surface, processed or not, achieved similar DMI as those fed in a ring or bunk, but wasted more hay. Delivering BP in a bunk or on the pen surface increased hay and supplement waste, respectively. Controlling access to hay reduced DMI and waste while maintaining cow BW.

Zinc supplementation strategies in feedlot heifers receiving an extended-release implant or an aggressive re-implant program.

Two hundred eight Angus-crossbred heifers (291 ± 23 kg) from four sources were used in a randomized complete block design. The objective of the study was to determine the effects of implant strategy and Zn supplementation on performance, carcass characteristics, muscle fiber diameter, and mineral status of heifers. Heifers were assigned to a 2 × 2 factorial study for 168 d, and factors included Zn and implant (IMP). Heifers were supplemented Zn (mg/kg dry matter [DM]; ZnSO4) at national (30; NRC) or industry (100; IND) recommendations. Implant strategies (Merck Animal Health, Madison, NJ) included extended-release Revalor-XH on day 0 (REV-XH; 20 mg estradiol + 200 mg trenbolone acetate) containing four uncoated pellets and six coated pellets or the uncoated implant Revalor-200 on day 0 and again on day 91 (REV-200; 20 mg estradiol + 200 mg trenbolone acetate). Heifers were blocked by weight within source to pens of five or six heifers per pen (nine pens per treatment). A corn silage-based diet was fed during the growing period (days 0-55) followed by transition to a corn-based finishing diet. Weights were taken consecutively on days -1/0, 55/56, and 167/168. Liver and muscle from the longissimus thoracis were collected from one heifer per pen on days -5, 14, 105, and 164. Data were analyzed via Mixed Procedure of SAS. Average daily gain (ADG) and liver mineral used Period as the repeated effect. Corresponding to periods of high hormone payout from each implant, days 0-28 and 91-120 ADG were greatest for REV-200, whereas REV-XH numerically peaked during days 56-91 (IMP × Period; P = 0.02). Day 91 IND body weight tended to be heavier (P = 0.06) and day 120 body weight was heavier (P = 0.05) than NRC heifers. No effect of Zn or IMP on final body weight was observed (P ≥ 0.21). Muscle fiber cross-sectional diameter on day 164 was greater (P = 0.05) in IND than NRC. Liver Mn concentrations decreased by day 14 regardless of implant, though days 105 and 164 concentrations were lesser for REV-200 than REV-XH (IMP × Period; P = 0.02). No effects of Zn, IMP, or the interaction were observed for carcass-adjusted gain to feed, days 0-168 DM intake, hot carcass weight, or ribeye area (P ≥ 0.11). The nominal differences in performance between implant strategies suggest that extended-release implants may be an effective implant strategy to replace re-implant programs in heifers, whereas the improved performance of heifers fed IND vs. NRC during times of peak hormone payout suggests a role for Zn in periods of rapid growth.

Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath.

Proving driving under the influence of cannabis (DUIC) is difficult. Establishing a biomarker of recent use to supplement behavioral observations may be a useful alternative strategy. We determined whether cannabinoid concentrations in blood, oral fluid (OF) or breath could identify use within the past 3 h-likely the period of the greatest impairment. In a randomized trial, 191 frequent (≥4/week) and occasional (<4/week) cannabis users smoked one cannabis (placebo [0.02%], or 5.9% or 13.4% Δ9-tetrahydrocannabinol [THC]) cigarette ad libitum. Blood, OF and breath samples were collected prior to and up to 6 h after smoking. Samples were analyzed for 10 cannabinoids in OF, 8 in blood and THC in breath. Frequent users had more residual THC in blood and were more likely to be categorized as 'recently used' prior to smoking; this did not occur in OF. Per se limits ranging from undetectable to 5 ng/mL THC in blood offered limited usefulness as biomarkers of recent use. Cannabinol (CBN, cutoff = 1 ng/mL) in blood offered 100% specificity but only 31.4% sensitivity, resulting in 100% positive predictive value (PPV) and 94.0% negative predictive value (NPV) at 4.3% prevalence; however, CBN may vary by cannabis chemovar. A 10 ng/mL THC cutoff in OF exhibited the overall highest performance to detect its use within 3 h (99.7% specificity, 82.4% sensitivity, 92.5% PPV and 99.2% NPV) but was still detectable in 23.2% of participants ∼4.4 h post-smoking, limiting specificity at later time points. OF THC may be a helpful indicator of recent cannabis intake, but this does not equate to impairment. Behavioral assessment of impairment is still required to determine DUIC. This study only involved cannabis inhalation, and additional research evaluating alternative routes of ingestion (i.e., oral) is needed.

The Canadian Neuromuscular Disease Registry 2010-2019: A Decade of Facilitating Clinical Research Througha Nationwide, Pan-NeuromuscularDisease Registry.

We report the recruitment activities and outcomes of a multi-disease neuromuscular patient registry in Canada. The Canadian Neuromuscular Disease Registry (CNDR) registers individuals across Canada with a confirmed diagnosis of a neuromuscular disease. Diagnosis and contact information are collected across all diseases and detailed prospective data is collected for 5 specific diseases: Amyotrophic Lateral Sclerosis (ALS), Duchenne Muscular Dystrophy (DMD), Myotonic Dystrophy (DM), Limb Girdle Muscular Dystrophy (LGMD), and Spinal Muscular Atrophy (SMA). Since 2010, the CNDR has registered 4306 patients (1154 pediatric and 3148 adult) with 91 different neuromuscular diagnoses and has facilitated 125 projects (73 academic, 3 not-for-profit, 3 government, and 46 commercial) using registry data. In conclusion, the CNDR is an effective and productive pan-neuromuscular registry that has successfully facilitated a substantial number of studies over the past 10 years.

Effectiveness of copper ions against Mycobacterium avium subsp. paratuberculosis and bacterial communities in naturally contaminated raw cow's milk.

AIM: The focus of the present study was to evaluate the copper ions treatment on the viability of Mycobacterium avium subsp. paratuberculosis (MAP) and other bacterial communities in cow's milk. METHODS AND RESULTS: A copper ions treatment was evaluated in naturally contaminated cow's milk to assay MAP load and/or viability, and relative abundance of other bacterial communities. In addition, physical-chemical analyses of the milk were also performed. All analyses were carried out before and after a copper ions treatment. After copper ions treatment, pH and copper concentration markedly increased in milk; the numbers of viable MAP significantly decreased. The relative abundance of the four target phyla decreased, with the phyla Bacteroidetes and Firmicutes surviving treatment in higher proportions (4 and 2·1% of original populations, respectively). A progressively higher percentage of dead bacterial cells after 5 and 20 min copper ions treatments was found (12 and 35%, respectively). CONCLUSION: With the exception of some MAP-tolerant strains, we have once again demonstrated that copper ions have a significant inactivating effect on MAP as well as certain other bacterial communities found in naturally contaminated cow's milk. SIGNIFICANCE AND IMPACT OF THE STUDY: This study showed a significant inactivation of both MAP and other bacteria by copper ions in raw cow's milk, information that could be useful as a tool for MAP control.

Remdesivir-Ivermectin combination displays synergistic interaction with improved in vitro antiviral activity against SARS-CoV-2

A key element for the prevention and management of COVID-19 is the development of effective therapeutics. Drug combination strategies of repurposed drugs offer several advantages over monotherapies, including the potential to achieve greater efficacy, the potential to increase the therapeutic index of drugs and the potential to reduce the emergence of drug resistance. Here, we report on the in vitro synergistic interaction between two FDA approved drugs, remdesivir and ivermectin resulting in enhanced antiviral activity against SARS-CoV-2. These findings warrant further investigations into the clinical potential of this combination, together with studies to define the underlying mechanism.

Parental ancestry and risk of early pregnancy loss at high altitude.

High altitude pregnancy is associated with increased frequency of low birth weight infants and neonatal complications, the risks of which are higher in women of low-altitude ancestry. Does ancestry also influence the risk of miscarriage (pregnancy loss <20 weeks) in high-altitude pregnancy? To answer this, 5386 women from La Paz, Bolivia (3300-4150 m) with ≥1 live-born infant were identified. Data were extracted from medical records including maternal and paternal ancestry, demographic factors, and reproductive history. The risk of miscarriage by ancestry was assessed using multivariate logistic regression, adjusting for parity, and maternal age. Andean women experienced first live-births younger than Mestizo or European women (21.7 ± 4.6 vs 23.4 ± 8.0 vs 24.1 ± 5.1, P < .001). Andeans experienced more pregnancies per year of reproductive life (P < .001) and had significantly higher ratios of live-births to miscarriages than women of Mestizo or European ancestry (P < .001). Andean women were 24% less likely to have ever experienced a miscarriage compared to European women (OR:0.76; CI:0.62-0.90, P < .001). The woman's partner's ancestry wasn't a significant independent predictor of miscarriage. In conclusion, the risk of miscarriage at high altitude is lower in Andean women. The lack of a paternal ancestry effect suggests underlying mechanisms relate more to differential maternal adaptation in early pregnancy than fetal genetics.

Diurnal and dietary impacts on estimating microbial protein flow from urinary purine derivative excretion in beef cattle.

Two experiments were conducted to determine the effects of diet composition and time of urine spot sampling on estimates of urinary purine derivative (PD) excretion. In Exp. 1, 116 individually fed crossbred heifers (407 ± 32 kg) were arranged in a randomized block design (82 d). Treatments were arranged in a 2 × 3 factorial design, with two urine spot sample collection times (0700 and 1700 hours; AM and PM) and three diets: 85% steam-flaked corn (SFC); 85% SFC + 1.5% urea (UREA); or 25% SFC, 30% wet corn gluten feed, and 30% corn bran (BYPROD). In Exp. 2, six ruminally and duodenally fistulated steers (474 ± 37 kg) were arranged in a replicated 3 × 3 Latin square design, with dietary treatments identical to Exp. 1 (63 d). Treatment diets were selected to result in varied amounts of microbial crude protein (MCP) in order to evaluate the accuracy of using estimates of urinary PD excretion to predict MCP. Urine spot samples were collected at 0700, 1200, 1700, and 2200 hours. No urine collection time × diet interactions occurred (P > 0.20) for any variable in either experiment. In Exp. 1, dry matter intake (DMI) was greatest with BYRPOD (10.40 kg/d) and lowest with SFC (7.90 kg/d; P < 0.05). Feed efficiencies were greatest for UREA (0.182) and least for SFC (0.141; P < 0.05). Urinary PD:creatinine (PD:C) ratio was greatest for BYPROD (1.25) and least for SFC (0.94; P < 0.05). Urine spot sampling time had a significant (P < 0.05) impact on PD:C, 1.03 for AM and 1.22 for PM samples. In Exp. 2, DMI was greater (P < 0.05) with BYPROD than with SFC and tended (P = 0.07) to be greater with BYPROD than with UREA. Ruminal pH was greatest for BYPROD (5.94; P < 0.05). Flow of MCP was 636, 829, and 1,056 g/d for SFC, UREA, and BYPROD, with BYPROD being greater (P < 0.05) than SFC and tending (P = 0.06) to be greater than UREA. Urinary PD:C was greater (P < 0.05) for BYPROD than SFC and tended (P = 0.09) to be greater for UREA than SFC. Urinary PD:C increased linearly (P < 0.05) with sampling time. Diets formulated to affect DMI and MCP flow resulted in differences in urinary PD excretion, and these results related well with MCP flow estimated from duodenal purines. Collecting spot samples of urine later in the day resulted in greater estimates of urinary PD excretion; purine and PD flows appear to increase with time after one morning feeding per day. This method is well suited to evaluating relative differences between treatments but should not be extrapolated to assume absolute values.

A pooled analysis of six large-pen feedlot studies: effects of a noncoated initial and terminal implant compared with a single initial and delayed-release implant on arrival in feedlot heifers.

Randomized complete block design experiments (n = 6 experiments) evaluating steroidal implants (all from Merck Animal Health, Madison, NJ) were conducted in large-pen feedlot research facilities between 2015 and 2018 comparing an 80 mg trenbolone acetate (TBA) and 8 mg estradiol-17ß (E2) initial implant (Revalor-IH) and reimplanted with 200 mg TBA and 20 mg E2 (Revalor-200; REPEATED) to a single 80 mg TBA and 8 mg E2 uncoated; 120 mg TBA and 12 mg E2 coated implant (Revalor-XH) at arrival (SINGLE) on growth and carcass responses in finishing heifers. Experiments occurred in Nebraska, Oklahoma, Washington, and Texas. Similar arrival processing was used across experiments where 17,675 heifers [initial body weight = 333 kg SEM (4.1)] were enrolled into 180 pens (90 pens per treatment with 65-240 heifers per pen) and fed for 145-222 d. Only REPEATED heifers were removed from their pen at reimplant. Diets contained monensin and tylosin, consisted of ingredients common to each region, and contained greater than 90% concentrate. Ractopamine hydrochloride was fed for a minimum of 28 d prior to harvest. Linear mixed models were used for all analyses; model-adjusted means for each implant group and the corresponding SEM were generated. Distributions of U.S. Department of Agriculture (USDA) quality grade (QG) and yield grade (YG) were analyzed as ordinal outcomes. No differences (P ≥ 0.11) were detected for any performance parameters except dry matter intake (DMI), where SINGLE had greater (P = 0.02) DMI (9.48 vs. 9.38 ± 0.127 kg) compared with REPEATED. Heifers implanted with REPEATED had greater (P ≤ 0.02) hot carcass weight (HCW; 384 vs. 382 ± 2.8 kg), dressing percentage (64.54 vs. 64.22 ± 0.120%), and ribeye area (91.87 vs. 89.55 ± 0.839 cm2) but less (P ≤ 0.01) rib fat (1.78 vs. 1.83 ± 0.025 cm) and calculated YG (2.82 vs. 2.97 ± 0.040) and similar (P = 0.74) marbling scores (503 vs. 505 ± 5.2) compared with SINGLE heifers. Distributions of USDA YG and QG were impacted (P ≤ 0.03) by treatment such that REPEATED had fewer USDA Prime and YG 4 and 5 carcasses. Heifer growth performance did not differ between implant regimens, but HCW and muscling did, perhaps indicating that REPEATED may be suited for grid-based marketing, and SINGLE might be suited for heifers sold on a live basis depending upon market conditions and value-based grid premiums and discounts. However, these decisions are operational dependent and also may be influenced by factors including animal and employee safety, stress on animals, processing facilities, time of year, labor availability, and marketing strategies.

Effect of bambermycin and dietary distillers grains concentration on growth performance and carcass characteristics of finishing steers.

An experiment was conducted comparing medicated feed additives (MFA) bambermycin or monensin sodium and tylosin phosphate in feedlot diets containing modified distillers grains (mDGS). Crossbred steers (n = 256; initial full BW 418 ± 28.5 kg) were allocated into three weight blocks in a randomized complete block design with a 2 × 2 factorial arrangement of treatments. The factors were: MFA (bambermycin at 20 mg/steer daily or monensin + tylosin at 380 and 90 mg/steer daily, respectively) and mDGS inclusion (15% and 30% of diet DM). Twenty-four pens were utilized, resulting in six replications per treatment. Steers were fed a diet consisting of a 1:1 combination of dry-rolled and high-moisture corn with the roughage portion of the diet consisting of corn silage and corn stover. Steers in the heaviest two blocks were marketed after 104 d and steers in the lightest block were marketed after 126 d. Overall average daily gain (ADG) tended (P = 0.08) to be greater for bambermycin vs. monensin and tylosin, and was not affected (P = 0.17) by mDGS level. Dry matter intake was lower (P ≤ 0.05) with 30% mDGS with monensin and tylosin than with any other treatment. Feed efficiency was not affected by mDGS, MFA, or their interaction (P ≥ 0.30). Marbling scores were greater (P = 0.01) greater for bambermycin vs. monensin and tylosin, and tended (P = 0.08) to be greater with 15% mDGS than with 30% mDGS. Carcasses from steers fed bambermycin had a greater percentage of USDA choice than those fed with monensin and tylosin (P = 0.01). Liver abscess occurrence was not affected (P ≥ 0.17) by MFA, mDGS, or their interaction. Results from this experiment indicate that including bambermycin in feedlot diets containing 30% mDGS results in increased DMI when compared with including monensin and tylosin in 30% mDGS diet without the risk for increases in liver abscess occurrence.

Milk Microbiota: What Are We Exactly Talking About?

The development of powerful sequencing techniques has allowed, albeit with some biases, the identification and inventory of complex microbial communities that inhabit different body sites or body fluids, some of which were previously considered sterile. Notably, milk is now considered to host a complex microbial community with great diversity. Milk microbiota is now well documented in various hosts. Based on the growing literature on this microbial community, we address here the question of what milk microbiota is. We summarize and compare the microbial composition of milk in humans and in ruminants and address the existence of a putative core milk microbiota. We discuss the factors that contribute to shape the milk microbiota or affect its composition, including host and environmental factors as well as methodological factors, such as the sampling and sequencing techniques, which likely introduce distortion in milk microbiota analysis. The roles that milk microbiota are likely to play in the mother and offspring physiology and health are presented together with recent data on the hypothesis of an enteromammary pathway. At last, this fascinating field raises a series of questions, which are listed and commented here and which open new research avenues.

Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort.

INTRODUCTION: Behavioral variant frontotemporal dementia (bvFTD) may present sporadically or due to an autosomal dominant mutation. Characterization of both forms will improve understanding of the generalizability of assessments and treatments. METHODS: A total of 135 sporadic (s-bvFTD; mean age 63.3 years; 34% female) and 99 familial (f-bvFTD; mean age 59.9; 48% female) bvFTD participants were identified. f-bvFTD cases included 43 with known or presumed chromosome 9 open reading frame 72 (C9orf72) gene expansions, 28 with known or presumed microtubule-associated protein tau (MAPT) mutations, 14 with known progranulin (GRN) mutations, and 14 with a strong family history of FTD but no identified mutation. RESULTS: Participants with f-bvFTD were younger and had earlier age at onset. s-bvFTD had higher total Neuropsychiatric Inventory Questionnaire (NPI-Q) scores due to more frequent endorsement of depression and irritability. DISCUSSION: f-bvFTD and s-bvFTD cases are clinically similar, suggesting the generalizability of novel biomarkers, therapies, and clinical tools developed in either form to the other.

Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection.

Dysregulated iron transport and a compromised blood-brain barrier are implicated in HIV-associated neurocognitive disorders (HAND). We quantified the levels of proteins involved in iron transport and/or angiogenesis-ceruloplasmin, haptoglobin, and vascular endothelial growth factor (VEGF)-as well as biomarkers of neuroinflammation, in cerebrospinal fluid (CSF) from 405 individuals with HIV infection and comprehensive neuropsychiatric assessments. Associations with HAND [defined by a Global Deficit Score (GDS) ≥ 0.5, GDS as a continuous measure (cGDS), or by Frascati criteria] were evaluated for the highest versus lowest tertile of each biomarker, adjusting for potential confounders. Higher CSF VEGF was associated with GDS-defined impairment [odds ratio (OR) 2.17, p = 0.006] and cGDS in unadjusted analyses and remained associated with GDS impairment after adjustment (p = 0.018). GDS impairment was also associated with higher CSF ceruloplasmin (p = 0.047) and with higher ceruloplasmin and haptoglobin in persons with minimal comorbidities (ORs 2.37 and 2.13, respectively; both p = 0.043). In persons with minimal comorbidities, higher ceruloplasmin and haptoglobin were associated with HAND by Frascati criteria (both p < 0.05), and higher ceruloplasmin predicted worse impairment (higher cGDS values, p < 0.01). In the subgroup with undetectable viral load and minimal comorbidity, CSF ceruloplasmin and haptoglobin were strongly associated with GDS impairment (ORs 5.57 and 2.96, respectively; both p < 0.01) and HAND (both p < 0.01). Concurrently measured CSF IL-6 and TNF-α were only weakly correlated to these three biomarkers. Higher CSF ceruloplasmin, haptoglobin, and VEGF are associated with a significantly greater likelihood of HAND, suggesting that interventions aimed at disordered iron transport and angiogenesis may be beneficial in this disorder.

Effects of a single initial and delayed release implant on arrival compared with a non-coated initial implant and a non-coated terminal implant in heifers fed across various days on feed.

Two experiments evaluated the effect of implant number, type, and total steroidal dose on live animal performance and carcass traits in heifers fed for three different days on feed (DOF). In experiment 1, heifers (n = 3,780; 70 heifers/pen and 9 pens/treatment; initial body weight [BW] = 309 kg) were used in a 2 × 3 factorial arrangement of treatments. Factors were as follows: 1) implant (all from Merck Animal Health, De Soto, KS): 200 mg trenbolone acetate (TBA) and 20 mg estradiol-17ß (E2) administered on arrival (SINGLE), or 80 mg TBA and 8 mg E2 administered on arrival followed by 200 mg TBA and 20 mg E2 after approximately 90 d (REPEATED) and 2) duration of DOF: harvested after approximately 172, 193, and 214. In experiment 2, heifers (n = 3,719; 65 to 70 heifers/pen and 9 pens/treatment; initial BW = 337 kg) were used with the same factors as experiment 1, except DOF were 150, 171, and 192. No implant × DOF interaction (P ≥ 0.06) was noted for any performance parameters in either experiment. Heifers administered REPEATED had improved (P ≤ 0.05) live gain to feed ratio (G:F) and carcass-adjusted G:F and tended (P = 0.09) to have greater hot carcass weight (HCW) in experiment 1. Increasing DOF resulted in greater (P ≤ 0.01) live and carcass-adjusted final BW and decreased (P = 0.01) live ADG in experiment 1. As DOF increased, HCW, HCW gain, and dressing% (P ≤ 0.01) increased in experiment 1. The mean carcass transfer was 79.6% across the 42 d terminal window in experiment 1. In experiment 2, REPEATED had improved (P = 0.03) carcass-adjusted G:F compared with SINGLE, but HCW was not different (P = 0.36) between treatments. Increased DOF resulted in greater (P ≤ 0.01) final live and carcass-adjusted BW, decreased (P ≤ 0.01) live and carcass-adjusted ADG, and poorer (P ≤ 0.01) live and carcass-adjusted G:F in experiment 2. In experiment 2, dressing percentage was greater (P = 0.02) in REPEATED compared with SINGLE. Heifers given SINGLE had greater (P = 0.01) back fat and estimated empty body fat (EBF), whereas REPEATED had fewer (P = 0.01) Yield Grade 4 carcasses and greater (P = 0.01) longissimus muscle (LM) area. Increased DOF resulted in greater (P ≤ 0.04) HCW, HCW gain, dressing%, back fat, LM area, marbling, EBF%, and United States Department of Agriculture (USDA) Prime-grading carcasses, Yield Grade 4 and 5, and over 454-kg carcasses in experiment 2. Carcass ADG and carcass transfer indicate a 0.70 kg carcass ADG between 150 and 192 DOF, resulting in an average carcass transfer of 72.2% in experiment 2. Although feedlot growth performance and HCW did not differ between the implant regimens tested, increasing DOF resulted in decreased live growth performance while increasing the proportion of USDA prime carcasses and HCW.

Gamifying CBT to deliver emotional health treatment to young people on smartphones.

mHealth interventions promise the economic delivery of evidence-based mental health treatments like cognitive behavioural therapy (CBT) to populations that struggle to access health services, such as adolescents and in New Zealand, Maori and Pasifika youth. Unfortunately engagement with digital therapies is poor; modularisation and gamification have potential to increase their appeal. Gamifying CBT involves selecting suitable interventions, adapting them to a digital format while applying gamification principles. We describe the design and development of Quest - Te Whitianga, an app that encourages the user to learn CBT skills via a series of activities and games. A variety of approaches including consultation with clinicians, reference to best-practice literature, focus groups and interactive workshops with youth were used to inform the co-design process. Clinicians worked iteratively with experienced game designers to co-create a youth CBT digital intervention. The Quest modular app is set on an ocean and the user travels between islands to learn six evidence-based skills. These include a relaxation/mindfulness activity, activity planning, a gratitude journal plus problem solving and communication skills training. We describe the theoretical and design aspects of each module detailing the gamified features that aim to increase user engagement. In the near future we will be testing the app and the principles discussed in this paper via a randomised-controlled trial.

In vitro inactivation of Mycobacterium avium subsp. paratuberculosis (MAP) by use of copper ions.

BACKGROUND: Mycobacterium avium subsp. paratuberculosis (MAP) is the causative agent of paratuberculosis, a contagious infectious disease that affects domestic and wild ruminants causing chronic inflammation of the intestine. MAP has proven to be very resistant to both physical and chemical processes, making it difficult to control this pathogen. Based on the recognized antimicrobial properties of copper, the objective of this study was to evaluate the effectiveness of copper ions to reduce MAP numbers and/or MAP viability in a fluid matrix. Besides, methicillin-resistant Staphylococcus aureus (MRSA), and Escherichia coli were used as controls of the effectiveness of copper ions. MAP-spiked PBS was subjected to copper ions treatment at 24 V for 5 min and the PBS suspensions were sampled before and after treatment. MAP viability and quantification were determined using three complementary techniques: a phage amplification assay, MGIT culture and qPCR. RESULTS: Moderate numbers (103 CFU ml-1) of the two control bacteria were completely eliminated by treatment with copper ions. For MAP, copper ions treatment reduced both the viability and numbers of this pathogen. Phage assay information quickly showed that copper ions (24 V for 5 min) resulted in a significant reduction in viable MAP. MGIT culture results over time showed statistically significant differences in time-to-detection (TTD) values between PRE and POST treatment. MAP genome equivalent estimates for PBS suspensions indicated that MAP numbers were lower in samples POST-treatment with copper ions than PRE-treatment. CONCLUSIONS: The use of copper ions resulted in a significant reduction of MAP in a liquid matrix, although some MAP survival on some occasions was observed.